Insider Form 4: CapsoVision director granted 2,887 RSUs with year-end vesting

Rhea-AI Filing Summary

CapsoVision, Inc. (CV) director Joanne Carol Imperial reported the receipt of 2,887 Restricted Stock Units (RSUs) on 09/15/2025. Each RSU converts into one share of common stock and the RSUs are scheduled to vest on December 31, 2025. The reported acquisition shows 2,887 shares beneficially owned following the grant on a direct basis at a reported price of $0. The Form 4 was signed by an attorney-in-fact and filed on 09/17/2025. No other transactions or derivative instruments are reported.

Positive

• Transparent disclosure of a director RSU grant with a clear vesting date (December 31, 2025).
• Alignment of interests between the director and shareholders through equity-based compensation.

Negative

• None.

Insights

Financial Analyst

TL;DR Routine equity grant to a director; modest size and time-based vesting imply limited immediate market impact.

This Form 4 documents a time-based grant of 2,887 RSUs to a director, which is a common component of executive and director compensation designed to align interests with shareholders. The grant vests at a future date, so there is no immediate issuance of shares or cash proceeds. For investors, the grant is informational about compensation practices but is not a material cash or financing event. The size (2,887 shares) should be evaluated relative to CapsoVision's outstanding share count to judge dilution, which is not provided in this filing.

Corporate Governance Expert

TL;DR Clear disclosure of a standard, time‑based RSU award to a director with an explicit vesting date and direct ownership.

The filing provides clean governance disclosure: the reporting person is a director and the award is explicitly described with a specified vesting date of December 31, 2025. The Form 4 is properly executed by an attorney-in-fact and filed promptly. This supports transparency in insider compensation practices. The filing does not include performance conditions or accelerated vesting terms; those details would require separate disclosure if present.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Imperial Joanne Carol

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CA 95070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	(1)	09/15/2025		A		2,887		(2)	(2)	Common Stock	2,887	$0	2,887	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. These RSUs are scheduled to vest on December 31, 2025

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Joanne Imperial	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Joanne Carol Imperial report on Form 4 for CapsoVision (CV)?

She reported receipt of 2,887 Restricted Stock Units (RSUs) acquired on 09/15/2025 that convert to one share each.

When do the RSUs reported for CV vest?

The RSUs are scheduled to vest on December 31, 2025.

How many shares does Joanne Imperial beneficially own after the reported transaction?

The filing indicates she beneficially owns 2,887 shares following the reported grant, held directly.

Was there any cash price reported for the RSU grant in the Form 4?

The Form 4 reports a price of $0, consistent with RSUs which convert to shares upon vesting rather than an immediate purchase.

Who signed and filed the Form 4 for Joanne Imperial?

The form was signed by an attorney-in-fact (Kang-Huai (Johnny) Wang) and filed on 09/17/2025.